Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

ALK ambiguous-positive non-small cell lung cancers are tumors challenged by diagnostic and therapeutic issues.

Oncology reports - 1 Sept 2016

Uguen Arnaud, Andrieu-Key Sophie, Vergne Florence, Descourt Renaud, Quéré Gilles, Quintin-Roué Isabelle, Key Stéphane, Guéguen Paul, Talagas Matthieu, De Braekeleer Marc, Marcorelles Pascale

Abstract excerpt

Searching for ALK rearrangements using the approved fluorescent in situ hybridization (FISH) test and complementary immunohistochemistry (IHC) has become the rule to treat patients with advanced non‑small cell lung cancer (NSCLC) with anti‑ALK targeted therapy. The concordance between the two techniques is reported to be strong but imperfect. We report our experience with cases of ALK‑rearranged lung...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma of Lung
Share to Anaplastic Lymphoma Kinase

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Crizotinib

Share to Gene Rearrangement

Share to Proto-Oncogene Proteins p21(ras)

Share to Pyrazoles

Share to Pyridines

Share to Receptor Protein-Tyrosine Kinases

Source

Identifiers

PMID: 27460205
DOI: 10.3892/or.2016.4962

Genes

ALK
EGFR
KRAS
MET

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

ALK ambiguous-positive non-small cell lung cancers are tumors challenged by diagnostic and therapeutic issues.PMID 27460205Read ↗

ALK-FISH borderline cases in non-small cell lung cancer: Implications for diagnostics and clinical decision makingSemantic proximity Read ↗

Discordance between FISH, IHC, and NGS Analysis of ALK Status in Advanced Non–Small Cell Lung Cancer (NSCLC): a Brief Report of 7 CasesSemantic proximity Read ↗

ALK testing in lung adenocarcinoma: technical aspects to improve FISH evaluation in daily practice.Semantic proximity Read ↗

Discrepancies between FISH and immunohistochemistry for assessment of the ALK status are associated with ALK 'borderline'-positive rearrangements or a high copy number: a potential major issue for anti-ALK therapeutic strategies.Semantic proximity Read ↗

Accurate Identification of ALK Positive Lung Carcinoma Patients: Novel FDA-Cleared Automated Fluorescence In Situ Hybridization Scanning System and Ultrasensitive ImmunohistochemistrySemantic proximity Read ↗

Combined use of ALK immunohistochemistry and FISH for optimal detection of ALK-rearranged lung adenocarcinomas.Semantic proximity Read ↗

ALK-rearranged lung cancer: adenosquamous lung cancer masquerading as pure squamous carcinoma.Semantic proximity Read ↗

Immunohistochemistry, Fluorescence in Situ Hybridization, and Reverse Transcription–Polymerase Chain Reaction for the Detection of Anaplastic Lymphoma Kinase Gene Rearrangements in Patients With Non–Small Cell Lung Cancer: Potential Advantages and Methodologic PitfallsSemantic proximity Read ↗

Anaplastic lymphoma kinase gene rearrangements in cytological samples of non-small cell lung cancer: comparison with histological assessment.Semantic proximity Read ↗

ALK FISH patterns and the detection of ALK fusions by next generation sequencing in lung adenocarcinoma.Semantic proximity Read ↗

Correlations between the percentage of tumor cells showing an anaplastic lymphoma kinase (ALK) gene rearrangement, ALK signal copy number, and response to crizotinib therapy in ALK fluorescence in situ hybridization–positive nonsmall cell lung cancerSemantic proximity Read ↗

Accurate and economical detection of ALK positive lung adenocarcinoma with semiquantitative immunohistochemical screening.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.